• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Unawareness of motor phenoconversion in Huntington disease.亨廷顿病运动表型转化的无意识。
Neurology. 2013 Sep 24;81(13):1141-7. doi: 10.1212/WNL.0b013e3182a55f05. Epub 2013 Aug 21.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Spiritual Well-Being and Phenoconversion in Huntington's Disease: Analysis from the Prospective Huntington at Risk Observational Study.亨廷顿舞蹈症中的精神健康与表型转换:来自前瞻性亨廷顿症风险观察研究的分析
J Palliat Med. 2025 Jun;28(6):803-807. doi: 10.1089/jpm.2024.0227. Epub 2025 Mar 5.
4
Cholinesterase inhibitors for rarer dementias associated with neurological conditions.用于治疗与神经疾病相关的罕见痴呆症的胆碱酯酶抑制剂。
Cochrane Database Syst Rev. 2015 Mar 3;2015(3):CD009444. doi: 10.1002/14651858.CD009444.pub3.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Outcomes of specialist physiotherapy for functional motor disorder: the Physio4FMD RCT.功能性运动障碍专科物理治疗的效果:Physio4FMD随机对照试验
Health Technol Assess. 2025 Jul;29(34):1-28. doi: 10.3310/MKAC9495.
9
Along-Tract Diffusion Alterations in the Dentato-Rubro-Thalamic Tract Correlate With Motor and Cognitive Decline in Huntington's Disease.齿状核-红核-丘脑束的长程扩散改变与亨廷顿舞蹈病的运动和认知衰退相关。
Hum Brain Mapp. 2025 Aug 1;46(11):e70305. doi: 10.1002/hbm.70305.
10
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.

引用本文的文献

1
Update on the Symptomatic Treatment of Huntington's Disease: From Pathophysiology to Clinical Practice.亨廷顿舞蹈症对症治疗的最新进展:从病理生理学到临床实践
Int J Mol Sci. 2025 Jun 27;26(13):6220. doi: 10.3390/ijms26136220.
2
Influence of anosognosia on patient-reported outcomes for psychiatric symptoms and quality of life in Huntington's disease.亨廷顿病患者病感缺失对精神症状和生活质量的患者报告结局的影响。
Parkinsonism Relat Disord. 2024 Jun;123:106969. doi: 10.1016/j.parkreldis.2024.106969. Epub 2024 Apr 9.
3
Impaired Self-Awareness in Parkinson's and Huntington's Diseases: A Literature Review of Neuroimaging Correlates.帕金森病和亨廷顿舞蹈病中的自我意识受损:神经影像学关联的文献综述
Brain Sci. 2024 Feb 23;14(3):204. doi: 10.3390/brainsci14030204.
4
Systemic Symptoms in Huntington's Disease: A Comprehensive Review.亨廷顿病的系统症状:全面综述。
Mov Disord Clin Pract. 2024 May;11(5):453-464. doi: 10.1002/mdc3.14029. Epub 2024 Mar 26.
5
"I don't have Huntington's disease": the boundaries between acceptance and understanding.“我没有亨廷顿舞蹈症”:接受与理解的界限。
Arq Neuropsiquiatr. 2023 Jul;81(7):696-699. doi: 10.1055/s-0043-1768158. Epub 2023 Jul 26.
6
Therapeutic Potential of Myricetin in the Treatment of Neurological, Neuropsychiatric, and Neurodegenerative Disorders.杨梅素在治疗神经、神经精神和神经退行性疾病方面的治疗潜力。
CNS Neurol Disord Drug Targets. 2024;23(7):865-882. doi: 10.2174/1871527322666230718105358.
7
Perceptions about Research Participation among Individuals at Risk and Individuals with Premanifest Huntington's Disease: A Survey Conducted by the European Huntington Association.欧洲亨廷顿病协会对亨廷顿病风险个体和症状前个体参与研究的认知情况调查
J Pers Med. 2021 Aug 20;11(8):815. doi: 10.3390/jpm11080815.
8
Clinical diagnosis and management in early Huntington's disease: a review.早期亨廷顿舞蹈病的临床诊断与管理:综述
Degener Neurol Neuromuscul Dis. 2015 Mar 25;5:37-50. doi: 10.2147/DNND.S49135. eCollection 2015.
9
Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease.亨廷顿舞蹈病患者中神经生活质量量表(Neuro-QoL)和患者报告结果测量信息系统心理健康量表(PROMIS)的有效性验证
J Huntingtons Dis. 2019;8(4):467-482. doi: 10.3233/JHD-190364.
10
Agreement between clinician-rated versus patient-reported outcomes in Huntington disease.在亨廷顿病中,临床医生评估与患者报告结局的一致性。
J Neurol. 2018 Jun;265(6):1443-1453. doi: 10.1007/s00415-018-8852-5. Epub 2018 Apr 23.

本文引用的文献

1
Indexing disease progression at study entry with individuals at-risk for Huntington disease.在研究开始时对亨廷顿病高危个体进行疾病进展的指标检测。
Am J Med Genet B Neuropsychiatr Genet. 2011 Dec;156B(7):751-63. doi: 10.1002/ajmg.b.31232. Epub 2011 Aug 19.
2
Self-awareness of motor dysfunction in patients with Huntington's disease in comparison to Parkinson's disease and cervical dystonia.亨廷顿病与帕金森病和痉挛性斜颈患者运动障碍的自我意识比较。
J Int Neuropsychol Soc. 2011 Sep;17(5):788-95. doi: 10.1017/S1355617711000725. Epub 2011 Jun 8.
3
Neurocognitive signs in prodromal Huntington disease.前驱期亨廷顿病的神经认知征象。
Neuropsychology. 2011 Jan;25(1):1-14. doi: 10.1037/a0020937.
4
Longitudinal change in regional brain volumes in prodromal Huntington disease.前驱期亨廷顿病患者脑区容积的纵向变化。
J Neurol Neurosurg Psychiatry. 2011 Apr;82(4):405-10. doi: 10.1136/jnnp.2010.208264. Epub 2010 Sep 30.
5
Fully automated analysis using BRAINS: AutoWorkup.使用 BRAINS:AutoWorkup 进行全自动分析。
Neuroimage. 2011 Jan 1;54(1):328-36. doi: 10.1016/j.neuroimage.2010.06.047. Epub 2010 Jun 25.
6
"Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness.亨廷顿病诊断前的“额叶”行为及其与疾病进展标志物的关系:早期缺乏意识的证据。
J Neuropsychiatry Clin Neurosci. 2010 Spring;22(2):196-207. doi: 10.1176/jnp.2010.22.2.196.
7
Factor analysis of behavioural symptoms in Huntington's disease.亨廷顿病行为症状的因子分析。
J Neurol Neurosurg Psychiatry. 2011 Apr;82(4):411-2. doi: 10.1136/jnnp.2009.181149. Epub 2010 Apr 14.
8
Striatal and white matter predictors of estimated diagnosis for Huntington disease.纹状体和白质对亨廷顿病预估诊断的预测。
Brain Res Bull. 2010 May 31;82(3-4):201-7. doi: 10.1016/j.brainresbull.2010.04.003. Epub 2010 Apr 10.
9
[Self-awareness of deficits in Huntington's and Parkinson's disease].[亨廷顿舞蹈症和帕金森病患者对自身缺陷的认知]
Psychiatr Pol. 2008 May-Jun;42(3):393-403.
10
Dementia and suicidal behavior: a review of the literature.痴呆与自杀行为:文献综述
Int Psychogeriatr. 2009 Jun;21(3):440-53. doi: 10.1017/S1041610209009065. Epub 2009 Apr 16.

亨廷顿病运动表型转化的无意识。

Unawareness of motor phenoconversion in Huntington disease.

机构信息

From the Neurology Department (E.A.M., D.G.G., C.T.L., K.R., J.G.), Westmead Hospital, Sydney; Sydney Medical School (E.A.M., C.T.L.), University of Sydney, Australia; and Department of Psychiatry (E.A.E., J.A.M., J.D.L, J.S.P.), University of Iowa, Iowa City.

出版信息

Neurology. 2013 Sep 24;81(13):1141-7. doi: 10.1212/WNL.0b013e3182a55f05. Epub 2013 Aug 21.

DOI:10.1212/WNL.0b013e3182a55f05
PMID:23966256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3795599/
Abstract

OBJECTIVE

To determine whether Huntington disease (HD) mutation carriers have motor symptoms (complaints) when definite motor onset (motor phenoconversion) is diagnosed and document differences between the groups with and without unawareness of motor signs.

METHODS

We analyzed data from 550 HD mutation carriers participating in the multicenter PREDICT-HD Study followed through the HD prodrome. Data analysis included demographics, the Unified Huntington's Disease Rating Scale (UHDRS) and the Participant HD History of symptoms, self-report of progression, and cognitive, behavioral, and imaging measures. Unawareness was identified when no motor symptoms were self-reported but when definite motor HD was diagnosed.

RESULTS

Of 38 (6.91%) with onset of motor HD, almost half (18/38 = 47.36%) had no motor symptoms despite signs of disease on the UHDRS motor rating and consistent with unawareness. A group with motor symptoms and signs was similar on a range of measures to the unaware group. Those with unawareness of HD signs reported less depression. Patients with symptoms had more striatal atrophy on imaging measures.

CONCLUSIONS

Only half of the patients with newly diagnosed motor HD had motor symptoms. Unaware patients were less likely to be depressed. Self-report of symptoms may be inaccurate in HD at the earliest stage.

摘要

目的

确定亨廷顿病(HD)突变携带者在明确的运动起始(运动表型转化)时是否出现运动症状(主诉),并记录有无运动迹象意识障碍的组间差异。

方法

我们分析了参加多中心 PREDICT-HD 研究并通过 HD 前驱期的 550 名 HD 突变携带者的数据。数据分析包括人口统计学、统一亨廷顿病评定量表(UHDRS)以及参与者的症状史、自我报告的进展、认知、行为和影像学测量。当无运动症状自我报告,但明确诊断为运动性 HD 时,则认为存在无症状。

结果

在 38 名(6.91%)出现运动性 HD 的患者中,尽管 UHDRS 运动评分存在疾病迹象且与无症状一致,但近一半(18/38 = 47.36%)无运动症状。有运动症状和体征的组在一系列测量指标上与无症状组相似。无症状组报告的抑郁症状较少。有症状的患者在影像学测量中基底节萎缩更明显。

结论

只有一半的新发运动性 HD 患者有运动症状。无症状患者的抑郁可能性较小。在 HD 的最早阶段,症状的自我报告可能不准确。